Journal of Medical Economics, Volume 17, Issue 1 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 17, Issue 1 (2014)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Volume 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Rheumatology: Original Article

Article
National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plans
Amie T. Joyce, Shravanthi R. Gandra, Kathleen M. Fox, Timothy W. Smith & Michael W. Pill
Pages: 1-10
Published online: 31 Oct 2013
AbstractforNational and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plans | Full Text | References | PDF (520.6 KB)
  • 601 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Diabetes: Original Articles

Article
Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2
Meryl Brod, Michael Wolden, Danielle Groleau & Donald M. Bushnell
Pages: 11-20
Published online: 12 Nov 2013
AbstractforUnderstanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2 | Full Text | References | PDF (187.2 KB)
  • 809 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study
Bradley Curtis & Maureen J. Lage
Pages: 21-31
Published online: 21 Nov 2013
AbstractforGlycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study | Full Text | References | PDF (207 KB)
  • 1214 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Oncology: Original Article

Article
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin’s lymphoma: cost-effectiveness analyses
Gregory Hill, Richard Barron, Kelly Fust, Michelle E. Skornicki, Douglas C. A. Taylor, Milton C. Weinstein & Gary H. Lyman
Pages: 32-42
Published online: 18 Oct 2013
AbstractforPrimary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin’s lymphoma: cost-effectiveness analyses | Full Text | References | PDF (509.1 KB)
  • 2376 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular: Original Articles

Article
The burden of preserved ejection fraction heart failure in a real-world Swedish patient population
Jan Stålhammar, Lee Stern, Ragnar Linder, Steve Sherman, Rohan Parikh, Rinat Ariely, Celine Deschaseaux & Gerhard Wikström
Pages: 43-51
Published online: 25 Oct 2013
AbstractforThe burden of preserved ejection fraction heart failure in a real-world Swedish patient population | Full Text | References | PDF (213.9 KB)
  • 781 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism
Patrick Lefebvre, Craig I. Coleman, Brahim K. Bookhart, Si-Tien Wang, Samir H. Mody, Kevin N. Tran, Daisy Y. Zhuo, Lynn Huynh & Edith A. Nutescu
Pages: 52-64
Published online: 14 Nov 2013
AbstractforCost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism | Full Text | References | PDF (377 KB) | Supplemental
  • 1808 Views
  • 51 CrossRef citations
  • 0Altmetric
Free Access

Infectious Disease: Original Articles

Article
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients
Sandrine Cure, Florence Bianic, Sandra Gavart, Steve Curtis, Seina Lee & Geoffrey Dusheiko
Pages: 65-76
Published online: 18 Nov 2013
AbstractforCost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients | Full Text | References | PDF (479.4 KB)
  • 678 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients
Sandrine Cure, Florence Bianic, Sandra Gavart, Steve Curtis, Seina Lee & Geoffrey Dusheiko
Pages: 77-87
Published online: 21 Nov 2013
AbstractforCost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients | Full Text | References | PDF (466.4 KB)
  • 556 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Explore articles